M. L. H. Vlaming Et Al. , "Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate," CLINICAL CANCER RESEARCH , vol.14, no.24, pp.8152-8160, 2008
Vlaming, M. L. H. Et Al. 2008. Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate. CLINICAL CANCER RESEARCH , vol.14, no.24 , 8152-8160.
Vlaming, M. L. H., Pala, Z., van Esch, A., Wagenaar, E., van Tellingen, O., de Waart, D. R., ... Elferink, R. P. J. O.(2008). Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate. CLINICAL CANCER RESEARCH , vol.14, no.24, 8152-8160.
Vlaming, Maria Et Al. "Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate," CLINICAL CANCER RESEARCH , vol.14, no.24, 8152-8160, 2008
Vlaming, Maria L. Et Al. "Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate." CLINICAL CANCER RESEARCH , vol.14, no.24, pp.8152-8160, 2008
Vlaming, M. L. H. Et Al. (2008) . "Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate." CLINICAL CANCER RESEARCH , vol.14, no.24, pp.8152-8160.
@article{article, author={Maria L. H. Vlaming Et Al. }, title={Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate}, journal={CLINICAL CANCER RESEARCH}, year=2008, pages={8152-8160} }